Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval ...

Novavax, Inc. (NVAX) shares jumped nearly 12.6% over the past week, leading to a surge in retail investor chatter following ...

After a 20% cut to the FDA’s workforce, biotechs and pharmas are bracing for delays. But the impacts won’t be consistent.

A summary of current health news, including the disbanding of a U.S. Justice Department unit focusing on food and drug safety ...

Takeda, a Japanese pharmaceutical company, plans to launch its dengue vaccine, Qdenga, in India next year in collaboration with Biological E. Clinical trials are underway, and the company aims to ...

Amazon, Apple, Meta, and Microsoft will need to address tariffs on earnings calls next week. Tech executives are sounding alarms. Brinker, the owner of Chili's, has seen shares soar 20% so far in 2025 ...

Shares in food delivery giant Deliveroo surged by 17% at the start of trading in London on Monday, following news that US-based rival DoorDash (DASH) had made a takeover approach. The bid, disclosed ...

Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark S&P 500 (SP500) jumping nearly 5%. For the week, the S&P advanced +4 ...

A study published last week suggests that, if vaccine uptake continues to decline, measles will soon be endemic again in the ...

Thermo Fisher Scientific and Danaher are projecting that their sales to academic and government (A&G) customers will shrink ...

Women have unique health issues. And some of the health issues that affect both men and women can affect women differently. Unique issues to women include pregnancy, menopause and conditions of ...